Carbapenem resistance among Enterobacteriaceae is one of the foremost challenges that the medical world is facing since the past few years. [1] Carbapenems were suggested as the final drug of choice for treatment during the emergence of ESBLs and AmpCs, due to their unique molecular structure and wide spectrum of activity. [2] But the origin of carbapenemase enzyme in Enterobacteriaceae poses a major threat, creating a dilemma in therapeutic methods. [3]
Prevalence of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital
Published 2019 in International Journal of Current Microbiology and Applied Sciences
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
International Journal of Current Microbiology and Applied Sciences
- Publication date
2019-11-10
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-22 of 22 references · Page 1 of 1
CITED BY
Showing 1-19 of 19 citing papers · Page 1 of 1